Enhancement of transfection activity of lipoplexes by complexation with transferrin-bearing fusogenic polymer-modified liposomes
- PMID: 16844328
- DOI: 10.1016/j.ijpharm.2006.06.015
Enhancement of transfection activity of lipoplexes by complexation with transferrin-bearing fusogenic polymer-modified liposomes
Abstract
We previously developed complexes of lipoplexes containing 3beta-(N-(N',N'-dimethylaminoethane)carbamoyl)cholesterol (DC-chol) and succinylated poly(glycidol)-modified liposome, which becomes fusogenic under weakly acidic condition, for use as a novel gene delivery system. This study explored the effect of lipoplex structures--the type of cationic lipid and cationic lipid/DNA charge ratio--on the transfection activity of those complexes. Three types of cationic lipid with different polar groups were used for the preparation of lipoplexes: DC-chol, N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate (DOTAP), and 3,5-dipentadecyloxybenzamidine (TRX-20) with dimethylamino group, trimethylammonium group, and benzamidine group, respectively. Complexation with the SucPG-modified transferrin-bearing liposomes affected transfection activity of these lipoplexes differently. The TRX-20 lipoplexes exhibited the most marked enhancement of transfection activity upon complexation with the SucPG-modified liposomes among these lipoplexes. The cationic lipid/DNA charge ratio of the lipoplex and the amount of the transferrin-bearing SucPG-modified liposomes associated to the lipoplex also affected the transfection activity of the resultant complexes. Highly potent gene vectors were obtained by adjusting these factors.
Similar articles
-
Novel gene delivery systems: complexes of fusigenic polymer-modified liposomes and lipoplexes.Gene Ther. 2001 Jan;8(1):5-12. doi: 10.1038/sj.gt.3301365. Gene Ther. 2001. PMID: 11402296
-
Generation of highly potent nonviral gene vectors by complexation of lipoplexes and transferrin-bearing fusogenic polymer-modified liposomes in aqueous glucose solution.Biomaterials. 2008 Mar;29(9):1262-72. doi: 10.1016/j.biomaterials.2007.11.016. Biomaterials. 2008. PMID: 18076985
-
Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.Int J Pharm. 2007 Sep 5;342(1-2):33-9. doi: 10.1016/j.ijpharm.2007.04.035. Epub 2007 May 10. Int J Pharm. 2007. PMID: 17566677
-
Lipoplex structures and their distinct cellular pathways.Adv Genet. 2005;53:119-55. Adv Genet. 2005. PMID: 16240992 Review.
-
Cationic liposomes for gene delivery.Expert Opin Drug Deliv. 2005 Mar;2(2):237-54. doi: 10.1517/17425247.2.2.237. Expert Opin Drug Deliv. 2005. PMID: 16296751 Review.
Cited by
-
Hepatocyte-targeting gene transfer mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine derivative.Drug Des Devel Ther. 2013;7:211-21. doi: 10.2147/DDDT.S42582. Epub 2013 Mar 26. Drug Des Devel Ther. 2013. PMID: 23576866 Free PMC article.
-
Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging.Biomaterials. 2014 Jun;35(18):4996-5005. doi: 10.1016/j.biomaterials.2014.03.007. Epub 2014 Mar 21. Biomaterials. 2014. PMID: 24661552 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources